John Wilkinson > Cooley (UK) LLP > London, England > Lawyer Profile
Cooley (UK) LLP Offices
22 Bishopsgate
LONDON
EC2N 4BQ
England
- Firm Profile
- Go to...
John Wilkinson
Work Department
Emerging Companies
Health Care
Intellectual Property
Life Sciences
Life Sciences Corporate Partnering & Licensing
Medical Devices
Mergers & Acquisitions
Public Companies
Position
John Wilkinson is partner in Cooley’s London office and his practice focuses primarily on the life sciences sector, advising pharmaceutical, biotechnology and medical technology companies on a wide range of IP, regulatory, antitrust and transactional matters. Amongst other things, John’s practice has involved a number of highly complex alliances and joint ventures, co-promotional and co-marketing arrangements, distribution and supply agreements, together with the operational, IP, antitrust and regulatory issues relating to such transactions.
Before qualifying as a lawyer, John obtained a degree in chemistry from Imperial College of Science Technology and Medicine and spent five years in the chemical and pharmaceutical industry working in drug development and other areas.
John advises pharmaceutical and biotechnology companies in the US, Canada, UK, Denmark, Hungary, Switzerland, Portugal, Sweden and Norway.
Career
Prior to joining Cooley, John was a partner at Reed Smith and previously at Bird & Bird. Prior to that, he was Legal Counsel at Cancer Research Technology Limited.
Before qualifying as a lawyer, John obtained a degree in chemistry from Imperial College of Science Technology and Medicine and spent five years in the chemical and pharmaceutical industry working in drug development and other areas.
Education
- College of Law, Chester
MAC Law Society Finals, 1993 - Imperial College
BS Chemistry, 1986
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
The team at Cooley (UK) LLP
is known for its ‘deep industry knowledge‘ and ‘unparalleled experience‘ in matters concerning clinical trials and manufacturing issues, and acts for a number of notable clients, including Hummingbird, Athenex, and Biograil. Nicola Maguire jointly leads the practice with John Wilkinson; Maguire assists a number of large bioscience and pharmaceutical companies with M&A and equity funding, while Wilkinson advises medtech companies on research collaborations and the purchase of vaccines. Frances Stocks Allen has broad expertise in acting for both public and private companies on supply arrangements, co-promotional issues and collaboration agreements.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > TMT
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- TMT (technology, media and telecoms) > IT and telecoms
- TMT (technology, media and telecoms) > IT and telecoms
Firm Rankings
- Industry focus > Life sciences and healthcare
- Insurance > Product liability: defendant
- Dispute resolution > Public international law
- Corporate and commercial > Venture capital
- Employment > Employee share schemes
- Corporate and commercial > Equity capital markets – mid-large cap
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)
- TMT (technology, media and telecoms) > Fintech
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > Corporate tax
- Risk advisory > Data protection, privacy and cybersecurity
- Crime, fraud and licensing > Fraud: civil
- Insurance > Insurance and reinsurance litigation
- Dispute resolution > Commercial litigation: premium
- Dispute resolution > International arbitration
- Employment > Employers
- Corporate and commercial > EU and competition
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)